Cargando…

Development and Characterization of Nanoparticles for the Delivery of Gemcitabine Hydrochloride

Gemcitabine (2,2-difluorodeoxycytidine) is a deoxycytidine analog, currently being used as a first-choice drug in pancreatic metastatic cancer. Gemcitabine is administered weekly as 30-minute infusion with starting dose ranging from 800 to 1250 mg/m(2). The aim of the present work was to develop sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaira, Rekha, Sharma, Jyoti, Saini, Vinay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925564/
https://www.ncbi.nlm.nih.gov/pubmed/24592173
http://dx.doi.org/10.1155/2014/560962

Ejemplares similares